EURAZEO to acquire PROTEOR

EURAZEO has agreed to acquire Proteor in a transaction announced on 21 October 2025. The deal concerns a company operating within the NaceV2Sector_C_32.50 classification, which relates to the manufacture of medical and dental instruments and supplies. No financial consideration or specific deal value has been disclosed in the available information regarding this acquisition. The target country for the business remains unreported in the current dataset.

The transaction is currently subject to regulatory approval and remains in the review phase. EURAZEO has not yet confirmed the completion of the acquisition as of the announcement date. The management team of Proteor has not been identified as the acquiring party in this specific arrangement. Further details regarding the finalisation of the deal are pending the outcome of the ongoing regulatory scrutiny. The parties involved continue to await the necessary clearances to proceed with the transfer of ownership.